BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19900450)

  • 1. Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis.
    Bishnupuri KS; Luo Q; Sainathan SK; Kikuchi K; Sureban SM; Sabarinathan M; Gross JH; Aden K; May R; Houchen CW; Anant S; Dieckgraefe BK
    Gastroenterology; 2010 Feb; 138(2):616-26, 626.e1-2. PubMed ID: 19900450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas.
    Bishnupuri KS; Luo Q; Murmu N; Houchen CW; Anant S; Dieckgraefe BK
    Gastroenterology; 2006 Jan; 130(1):137-49. PubMed ID: 16401477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes.
    Bishnupuri KS; Luo Q; Korzenik JR; Henderson JO; Houchen CW; Anant S; Dieckgraefe BK
    Cancer Biol Ther; 2006 Dec; 5(12):1714-20. PubMed ID: 17106246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin.
    Sun C; Fukui H; Hara K; Kitayama Y; Eda H; Yang M; Yamagishi H; Tomita T; Oshima T; Watari J; Takasawa S; Chiba T; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G736-44. PubMed ID: 25747353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.
    Yang J; Sun M; Zhang A; Lv C; De W; Wang Z
    World J Surg Oncol; 2011 Oct; 9():117. PubMed ID: 21970601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
    Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
    Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin expression and cell survival regulation in colorectal cancer.
    Leiphrakpam PD; Rajput A; Mathiesen M; Agarwal E; Lazenby AJ; Are C; Brattain MG; Chowdhury S
    Cell Signal; 2014 May; 26(5):868-79. PubMed ID: 24462708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reg IV enhances peritoneal metastasis in gastric carcinomas.
    Kuniyasu H; Oue N; Sasahira T; Yi L; Moriwaka Y; Shimomoto T; Fujii K; Ohmori H; Yasui W
    Cell Prolif; 2009 Feb; 42(1):110-21. PubMed ID: 19143768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of survivin on tumor growth of colorectal cancer in vivo.
    Cai Y; Ma W; Huang X; Cao L; Li H; Jiang Y; Lu N; Yin Y
    Int J Clin Exp Pathol; 2015; 8(10):13267-72. PubMed ID: 26722528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
    Vanderlaag K; Wang W; Fayadat-Dilman L; Wagner J; Bald L; Grein J; Janatpour MJ
    Int J Cancer; 2012 Mar; 130(6):1251-63. PubMed ID: 21445968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
    Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
    World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
    Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Reg IV in colorectal adenoma.
    Zhang Y; Lai M; Lv B; Gu X; Wang H; Zhu Y; Zhu Y; Shao L; Wang G
    Cancer Lett; 2003 Oct; 200(1):69-76. PubMed ID: 14550954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.
    Scherr AL; Mock A; Gdynia G; Schmitt N; Heilig CE; Korell F; Rhadakrishnan P; Hoffmeister P; Metzeler KH; Schulze-Osthoff K; Illert AL; Boerries M; Trojan J; Waidmann O; Falkenhorst J; Siveke J; Jost PJ; Bitzer M; Malek NP; Vecchione L; Jelas I; Brors B; Glimm H; Stenzinger A; Grekova SP; Gehrig T; Schulze-Bergkamen H; Jäger D; Schirmacher P; Heikenwalder M; Goeppert B; Schneider M; Fröhling S; Köhler BC
    Cell Death Dis; 2020 Oct; 11(10):875. PubMed ID: 33070156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.